Quinotolast

Quinotolast is an orally active antiallergic agent. Quinotolast inhibits histamine release from rat peritoneal cells. Quinotolast inhibits cutaneous cromoglycate in guinea pig model. Quinotolast has inhibitory effect on histamine and peptide leukotrienes release from guinea pig lung fragments and mouse cultured mast cells. Quinotolast can be studied in allergy-related research[1].

Product Specifications

CAS Number

[101193-40-2]

UNSPSC

12352005

Target

Histamine Receptor

Related Pathways

GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Smiles

O=C(C1=CC(OC2=CC=CC=C2)=C3C=CC=CN3C1=O)NC4=NN=NN4

Molecular Formula

C17H12N6O3

Molecular Weight

348.32

References & Citations

[1]Kobayashi, K., et al., (1993) . Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Japanese journal of pharmacology, 63 (1), 73-81.